The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Equine Rabies Immunoglobulin (ERIG) Market Research Report 2025
Synopsis
Equine rabies immunoglobulin (ERIG) is a biological product derived from horse blood plasma used as passive immunity against rabies virus.
The global Equine Rabies Immunoglobulin (ERIG) market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The market for equine rabies immunoglobulin is driven by its role as a protective treatment for rabies exposure, especially in regions where human rabies immune globulin (HRIG) may not be readily available. ERIG is used in combination with the rabies vaccine to prevent rabies infection. As rabies prevention remains a priority in animal healthcare and public health, the market for ERIG is expected to continue.
This report aims to provide a comprehensive presentation of the global market for Equine Rabies Immunoglobulin (ERIG), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Equine Rabies Immunoglobulin (ERIG).
Report Scope
The Equine Rabies Immunoglobulin (ERIG) market size, estimations, and forecasts are provided in terms of sales volume (Kiloton) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Equine Rabies Immunoglobulin (ERIG) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Equine Rabies Immunoglobulin (ERIG) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Serum China
Lanzhou Institute of Biological Products
Wuhan Institute of Biological Products
Premium Serums
Haffkine Bio-Pharmaceutical
Bharat Serums
Segment by Type
1500IU
1000IU
400IU
Other
Segment by Application
Category II Exposure
Category III Exposure
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Equine Rabies Immunoglobulin (ERIG) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Equine Rabies Immunoglobulin (ERIG) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Equine rabies immunoglobulin (ERIG) is a biological product derived from horse blood plasma used as passive immunity against rabies virus.
The global Equine Rabies Immunoglobulin (ERIG) market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The market for equine rabies immunoglobulin is driven by its role as a protective treatment for rabies exposure, especially in regions where human rabies immune globulin (HRIG) may not be readily available. ERIG is used in combination with the rabies vaccine to prevent rabies infection. As rabies prevention remains a priority in animal healthcare and public health, the market for ERIG is expected to continue.
This report aims to provide a comprehensive presentation of the global market for Equine Rabies Immunoglobulin (ERIG), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Equine Rabies Immunoglobulin (ERIG).
Report Scope
The Equine Rabies Immunoglobulin (ERIG) market size, estimations, and forecasts are provided in terms of sales volume (Kiloton) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Equine Rabies Immunoglobulin (ERIG) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Equine Rabies Immunoglobulin (ERIG) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Serum China
Lanzhou Institute of Biological Products
Wuhan Institute of Biological Products
Premium Serums
Haffkine Bio-Pharmaceutical
Bharat Serums
Segment by Type
1500IU
1000IU
400IU
Other
Segment by Application
Category II Exposure
Category III Exposure
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Equine Rabies Immunoglobulin (ERIG) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Equine Rabies Immunoglobulin (ERIG) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Equine Rabies Immunoglobulin (ERIG) Market Overview
1.1 Product Overview and Scope of Equine Rabies Immunoglobulin (ERIG)
1.2 Equine Rabies Immunoglobulin (ERIG) Segment by Type
1.2.1 Global Equine Rabies Immunoglobulin (ERIG) Market Value Comparison by Type (2024-2030)
1.2.2 1500IU
1.2.3 1000IU
1.2.4 400IU
1.2.5 Other
1.3 Equine Rabies Immunoglobulin (ERIG) Segment by Application
1.3.1 Global Equine Rabies Immunoglobulin (ERIG) Market Value by Application: (2024-2030)
1.3.2 Category II Exposure
1.3.3 Category III Exposure
1.4 Global Equine Rabies Immunoglobulin (ERIG) Market Size Estimates and Forecasts
1.4.1 Global Equine Rabies Immunoglobulin (ERIG) Revenue 2019-2030
1.4.2 Global Equine Rabies Immunoglobulin (ERIG) Sales 2019-2030
1.4.3 Global Equine Rabies Immunoglobulin (ERIG) Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Equine Rabies Immunoglobulin (ERIG) Market Competition by Manufacturers
2.1 Global Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Manufacturers (2019-2024)
2.2 Global Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Equine Rabies Immunoglobulin (ERIG) Average Price by Manufacturers (2019-2024)
2.4 Global Equine Rabies Immunoglobulin (ERIG) Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Equine Rabies Immunoglobulin (ERIG), Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Equine Rabies Immunoglobulin (ERIG), Product Type & Application
2.7 Equine Rabies Immunoglobulin (ERIG) Market Competitive Situation and Trends
2.7.1 Equine Rabies Immunoglobulin (ERIG) Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Equine Rabies Immunoglobulin (ERIG) Players Market Share by Revenue
2.7.3 Global Equine Rabies Immunoglobulin (ERIG) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Equine Rabies Immunoglobulin (ERIG) Retrospective Market Scenario by Region
3.1 Global Equine Rabies Immunoglobulin (ERIG) Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Equine Rabies Immunoglobulin (ERIG) Global Equine Rabies Immunoglobulin (ERIG) Sales by Region: 2019-2030
3.2.1 Global Equine Rabies Immunoglobulin (ERIG) Sales by Region: 2019-2024
3.2.2 Global Equine Rabies Immunoglobulin (ERIG) Sales by Region: 2025-2030
3.3 Global Equine Rabies Immunoglobulin (ERIG) Global Equine Rabies Immunoglobulin (ERIG) Revenue by Region: 2019-2030
3.3.1 Global Equine Rabies Immunoglobulin (ERIG) Revenue by Region: 2019-2024
3.3.2 Global Equine Rabies Immunoglobulin (ERIG) Revenue by Region: 2025-2030
3.4 North America Equine Rabies Immunoglobulin (ERIG) Market Facts & Figures by Country
3.4.1 North America Equine Rabies Immunoglobulin (ERIG) Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Equine Rabies Immunoglobulin (ERIG) Sales by Country (2019-2030)
3.4.3 North America Equine Rabies Immunoglobulin (ERIG) Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Equine Rabies Immunoglobulin (ERIG) Market Facts & Figures by Country
3.5.1 Europe Equine Rabies Immunoglobulin (ERIG) Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Equine Rabies Immunoglobulin (ERIG) Sales by Country (2019-2030)
3.5.3 Europe Equine Rabies Immunoglobulin (ERIG) Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Equine Rabies Immunoglobulin (ERIG) Market Facts & Figures by Country
3.6.1 Asia Pacific Equine Rabies Immunoglobulin (ERIG) Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Equine Rabies Immunoglobulin (ERIG) Sales by Country (2019-2030)
3.6.3 Asia Pacific Equine Rabies Immunoglobulin (ERIG) Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Equine Rabies Immunoglobulin (ERIG) Market Facts & Figures by Country
3.7.1 Latin America Equine Rabies Immunoglobulin (ERIG) Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Equine Rabies Immunoglobulin (ERIG) Sales by Country (2019-2030)
3.7.3 Latin America Equine Rabies Immunoglobulin (ERIG) Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Equine Rabies Immunoglobulin (ERIG) Market Facts & Figures by Country
3.8.1 Middle East and Africa Equine Rabies Immunoglobulin (ERIG) Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Equine Rabies Immunoglobulin (ERIG) Sales by Country (2019-2030)
3.8.3 Middle East and Africa Equine Rabies Immunoglobulin (ERIG) Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Equine Rabies Immunoglobulin (ERIG) Sales by Type (2019-2030)
4.1.1 Global Equine Rabies Immunoglobulin (ERIG) Sales by Type (2019-2024)
4.1.2 Global Equine Rabies Immunoglobulin (ERIG) Sales by Type (2025-2030)
4.1.3 Global Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Type (2019-2030)
4.2 Global Equine Rabies Immunoglobulin (ERIG) Revenue by Type (2019-2030)
4.2.1 Global Equine Rabies Immunoglobulin (ERIG) Revenue by Type (2019-2024)
4.2.2 Global Equine Rabies Immunoglobulin (ERIG) Revenue by Type (2025-2030)
4.2.3 Global Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Type (2019-2030)
4.3 Global Equine Rabies Immunoglobulin (ERIG) Price by Type (2019-2030)
5 Segment by Application
5.1 Global Equine Rabies Immunoglobulin (ERIG) Sales by Application (2019-2030)
5.1.1 Global Equine Rabies Immunoglobulin (ERIG) Sales by Application (2019-2024)
5.1.2 Global Equine Rabies Immunoglobulin (ERIG) Sales by Application (2025-2030)
5.1.3 Global Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Application (2019-2030)
5.2 Global Equine Rabies Immunoglobulin (ERIG) Revenue by Application (2019-2030)
5.2.1 Global Equine Rabies Immunoglobulin (ERIG) Revenue by Application (2019-2024)
5.2.2 Global Equine Rabies Immunoglobulin (ERIG) Revenue by Application (2025-2030)
5.2.3 Global Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Application (2019-2030)
5.3 Global Equine Rabies Immunoglobulin (ERIG) Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Serum China
6.1.1 Serum China Corporation Information
6.1.2 Serum China Description and Business Overview
6.1.3 Serum China Equine Rabies Immunoglobulin (ERIG) Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Serum China Equine Rabies Immunoglobulin (ERIG) Product Portfolio
6.1.5 Serum China Recent Developments/Updates
6.2 Lanzhou Institute of Biological Products
6.2.1 Lanzhou Institute of Biological Products Corporation Information
6.2.2 Lanzhou Institute of Biological Products Description and Business Overview
6.2.3 Lanzhou Institute of Biological Products Equine Rabies Immunoglobulin (ERIG) Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Lanzhou Institute of Biological Products Equine Rabies Immunoglobulin (ERIG) Product Portfolio
6.2.5 Lanzhou Institute of Biological Products Recent Developments/Updates
6.3 Wuhan Institute of Biological Products
6.3.1 Wuhan Institute of Biological Products Corporation Information
6.3.2 Wuhan Institute of Biological Products Description and Business Overview
6.3.3 Wuhan Institute of Biological Products Equine Rabies Immunoglobulin (ERIG) Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Wuhan Institute of Biological Products Equine Rabies Immunoglobulin (ERIG) Product Portfolio
6.3.5 Wuhan Institute of Biological Products Recent Developments/Updates
6.4 Premium Serums
6.4.1 Premium Serums Corporation Information
6.4.2 Premium Serums Description and Business Overview
6.4.3 Premium Serums Equine Rabies Immunoglobulin (ERIG) Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Premium Serums Equine Rabies Immunoglobulin (ERIG) Product Portfolio
6.4.5 Premium Serums Recent Developments/Updates
6.5 Haffkine Bio-Pharmaceutical
6.5.1 Haffkine Bio-Pharmaceutical Corporation Information
6.5.2 Haffkine Bio-Pharmaceutical Description and Business Overview
6.5.3 Haffkine Bio-Pharmaceutical Equine Rabies Immunoglobulin (ERIG) Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Haffkine Bio-Pharmaceutical Equine Rabies Immunoglobulin (ERIG) Product Portfolio
6.5.5 Haffkine Bio-Pharmaceutical Recent Developments/Updates
6.6 Bharat Serums
6.6.1 Bharat Serums Corporation Information
6.6.2 Bharat Serums Description and Business Overview
6.6.3 Bharat Serums Equine Rabies Immunoglobulin (ERIG) Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Bharat Serums Equine Rabies Immunoglobulin (ERIG) Product Portfolio
6.6.5 Bharat Serums Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Equine Rabies Immunoglobulin (ERIG) Industry Chain Analysis
7.2 Equine Rabies Immunoglobulin (ERIG) Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Equine Rabies Immunoglobulin (ERIG) Production Mode & Process
7.4 Equine Rabies Immunoglobulin (ERIG) Sales and Marketing
7.4.1 Equine Rabies Immunoglobulin (ERIG) Sales Channels
7.4.2 Equine Rabies Immunoglobulin (ERIG) Distributors
7.5 Equine Rabies Immunoglobulin (ERIG) Customers
8 Equine Rabies Immunoglobulin (ERIG) Market Dynamics
8.1 Equine Rabies Immunoglobulin (ERIG) Industry Trends
8.2 Equine Rabies Immunoglobulin (ERIG) Market Drivers
8.3 Equine Rabies Immunoglobulin (ERIG) Market Challenges
8.4 Equine Rabies Immunoglobulin (ERIG) Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Equine Rabies Immunoglobulin (ERIG) Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Equine Rabies Immunoglobulin (ERIG) Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Equine Rabies Immunoglobulin (ERIG) Market Competitive Situation by Manufacturers in 2023
Table 4. Global Equine Rabies Immunoglobulin (ERIG) Sales (Kiloton) of Key Manufacturers (2019-2024)
Table 5. Global Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Equine Rabies Immunoglobulin (ERIG) Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Equine Rabies Immunoglobulin (ERIG) Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Equine Rabies Immunoglobulin (ERIG) Average Price (US$/Ton) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Equine Rabies Immunoglobulin (ERIG), Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Equine Rabies Immunoglobulin (ERIG), Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Equine Rabies Immunoglobulin (ERIG), Product Type & Application
Table 12. Global Key Manufacturers of Equine Rabies Immunoglobulin (ERIG), Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Equine Rabies Immunoglobulin (ERIG) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Equine Rabies Immunoglobulin (ERIG) as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Equine Rabies Immunoglobulin (ERIG) Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Equine Rabies Immunoglobulin (ERIG) Sales by Region (2019-2024) & (Kiloton)
Table 18. Global Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Region (2019-2024)
Table 19. Global Equine Rabies Immunoglobulin (ERIG) Sales by Region (2025-2030) & (Kiloton)
Table 20. Global Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Region (2025-2030)
Table 21. Global Equine Rabies Immunoglobulin (ERIG) Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Region (2019-2024)
Table 23. Global Equine Rabies Immunoglobulin (ERIG) Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Region (2025-2030)
Table 25. North America Equine Rabies Immunoglobulin (ERIG) Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Equine Rabies Immunoglobulin (ERIG) Sales by Country (2019-2024) & (Kiloton)
Table 27. North America Equine Rabies Immunoglobulin (ERIG) Sales by Country (2025-2030) & (Kiloton)
Table 28. North America Equine Rabies Immunoglobulin (ERIG) Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Equine Rabies Immunoglobulin (ERIG) Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Equine Rabies Immunoglobulin (ERIG) Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Equine Rabies Immunoglobulin (ERIG) Sales by Country (2019-2024) & (Kiloton)
Table 32. Europe Equine Rabies Immunoglobulin (ERIG) Sales by Country (2025-2030) & (Kiloton)
Table 33. Europe Equine Rabies Immunoglobulin (ERIG) Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Equine Rabies Immunoglobulin (ERIG) Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Equine Rabies Immunoglobulin (ERIG) Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Equine Rabies Immunoglobulin (ERIG) Sales by Region (2019-2024) & (Kiloton)
Table 37. Asia Pacific Equine Rabies Immunoglobulin (ERIG) Sales by Region (2025-2030) & (Kiloton)
Table 38. Asia Pacific Equine Rabies Immunoglobulin (ERIG) Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Equine Rabies Immunoglobulin (ERIG) Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Equine Rabies Immunoglobulin (ERIG) Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Equine Rabies Immunoglobulin (ERIG) Sales by Country (2019-2024) & (Kiloton)
Table 42. Latin America Equine Rabies Immunoglobulin (ERIG) Sales by Country (2025-2030) & (Kiloton)
Table 43. Latin America Equine Rabies Immunoglobulin (ERIG) Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Equine Rabies Immunoglobulin (ERIG) Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Equine Rabies Immunoglobulin (ERIG) Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Equine Rabies Immunoglobulin (ERIG) Sales by Country (2019-2024) & (Kiloton)
Table 47. Middle East & Africa Equine Rabies Immunoglobulin (ERIG) Sales by Country (2025-2030) & (Kiloton)
Table 48. Middle East & Africa Equine Rabies Immunoglobulin (ERIG) Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Equine Rabies Immunoglobulin (ERIG) Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Equine Rabies Immunoglobulin (ERIG) Sales (Kiloton) by Type (2019-2024)
Table 51. Global Equine Rabies Immunoglobulin (ERIG) Sales (Kiloton) by Type (2025-2030)
Table 52. Global Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Type (2019-2024)
Table 53. Global Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Type (2025-2030)
Table 54. Global Equine Rabies Immunoglobulin (ERIG) Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Equine Rabies Immunoglobulin (ERIG) Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Type (2019-2024)
Table 57. Global Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Type (2025-2030)
Table 58. Global Equine Rabies Immunoglobulin (ERIG) Price (US$/Ton) by Type (2019-2024)
Table 59. Global Equine Rabies Immunoglobulin (ERIG) Price (US$/Ton) by Type (2025-2030)
Table 60. Global Equine Rabies Immunoglobulin (ERIG) Sales (Kiloton) by Application (2019-2024)
Table 61. Global Equine Rabies Immunoglobulin (ERIG) Sales (Kiloton) by Application (2025-2030)
Table 62. Global Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Application (2019-2024)
Table 63. Global Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Application (2025-2030)
Table 64. Global Equine Rabies Immunoglobulin (ERIG) Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Equine Rabies Immunoglobulin (ERIG) Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Application (2019-2024)
Table 67. Global Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Application (2025-2030)
Table 68. Global Equine Rabies Immunoglobulin (ERIG) Price (US$/Ton) by Application (2019-2024)
Table 69. Global Equine Rabies Immunoglobulin (ERIG) Price (US$/Ton) by Application (2025-2030)
Table 70. Serum China Corporation Information
Table 71. Serum China Description and Business Overview
Table 72. Serum China Equine Rabies Immunoglobulin (ERIG) Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 73. Serum China Equine Rabies Immunoglobulin (ERIG) Product
Table 74. Serum China Recent Developments/Updates
Table 75. Lanzhou Institute of Biological Products Corporation Information
Table 76. Lanzhou Institute of Biological Products Description and Business Overview
Table 77. Lanzhou Institute of Biological Products Equine Rabies Immunoglobulin (ERIG) Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 78. Lanzhou Institute of Biological Products Equine Rabies Immunoglobulin (ERIG) Product
Table 79. Lanzhou Institute of Biological Products Recent Developments/Updates
Table 80. Wuhan Institute of Biological Products Corporation Information
Table 81. Wuhan Institute of Biological Products Description and Business Overview
Table 82. Wuhan Institute of Biological Products Equine Rabies Immunoglobulin (ERIG) Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 83. Wuhan Institute of Biological Products Equine Rabies Immunoglobulin (ERIG) Product
Table 84. Wuhan Institute of Biological Products Recent Developments/Updates
Table 85. Premium Serums Corporation Information
Table 86. Premium Serums Description and Business Overview
Table 87. Premium Serums Equine Rabies Immunoglobulin (ERIG) Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 88. Premium Serums Equine Rabies Immunoglobulin (ERIG) Product
Table 89. Premium Serums Recent Developments/Updates
Table 90. Haffkine Bio-Pharmaceutical Corporation Information
Table 91. Haffkine Bio-Pharmaceutical Description and Business Overview
Table 92. Haffkine Bio-Pharmaceutical Equine Rabies Immunoglobulin (ERIG) Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 93. Haffkine Bio-Pharmaceutical Equine Rabies Immunoglobulin (ERIG) Product
Table 94. Haffkine Bio-Pharmaceutical Recent Developments/Updates
Table 95. Bharat Serums Corporation Information
Table 96. Bharat Serums Description and Business Overview
Table 97. Bharat Serums Equine Rabies Immunoglobulin (ERIG) Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 98. Bharat Serums Equine Rabies Immunoglobulin (ERIG) Product
Table 99. Bharat Serums Recent Developments/Updates
Table 100. Key Raw Materials Lists
Table 101. Raw Materials Key Suppliers Lists
Table 102. Equine Rabies Immunoglobulin (ERIG) Distributors List
Table 103. Equine Rabies Immunoglobulin (ERIG) Customers List
Table 104. Equine Rabies Immunoglobulin (ERIG) Market Trends
Table 105. Equine Rabies Immunoglobulin (ERIG) Market Drivers
Table 106. Equine Rabies Immunoglobulin (ERIG) Market Challenges
Table 107. Equine Rabies Immunoglobulin (ERIG) Market Restraints
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Equine Rabies Immunoglobulin (ERIG)
Figure 2. Global Equine Rabies Immunoglobulin (ERIG) Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Equine Rabies Immunoglobulin (ERIG) Market Share by Type in 2023 & 2030
Figure 4. 1500IU Product Picture
Figure 5. 1000IU Product Picture
Figure 6. 400IU Product Picture
Figure 7. Other Product Picture
Figure 8. Global Equine Rabies Immunoglobulin (ERIG) Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 9. Global Equine Rabies Immunoglobulin (ERIG) Market Share by Application in 2023 & 2030
Figure 10. Category II Exposure
Figure 11. Category III Exposure
Figure 12. Global Equine Rabies Immunoglobulin (ERIG) Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Equine Rabies Immunoglobulin (ERIG) Market Size (2019-2030) & (US$ Million)
Figure 14. Global Equine Rabies Immunoglobulin (ERIG) Sales (2019-2030) & (Kiloton)
Figure 15. Global Equine Rabies Immunoglobulin (ERIG) Average Price (US$/Ton) & (2019-2030)
Figure 16. Equine Rabies Immunoglobulin (ERIG) Report Years Considered
Figure 17. Equine Rabies Immunoglobulin (ERIG) Sales Share by Manufacturers in 2023
Figure 18. Global Equine Rabies Immunoglobulin (ERIG) Revenue Share by Manufacturers in 2023
Figure 19. The Global 5 and 10 Largest Equine Rabies Immunoglobulin (ERIG) Players: Market Share by Revenue in 2023
Figure 20. Equine Rabies Immunoglobulin (ERIG) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 21. Global Equine Rabies Immunoglobulin (ERIG) Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 22. North America Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Country (2019-2030)
Figure 23. North America Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Country (2019-2030)
Figure 24. United States Equine Rabies Immunoglobulin (ERIG) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Canada Equine Rabies Immunoglobulin (ERIG) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Europe Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Country (2019-2030)
Figure 27. Europe Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Country (2019-2030)
Figure 28. Germany Equine Rabies Immunoglobulin (ERIG) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. France Equine Rabies Immunoglobulin (ERIG) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. U.K. Equine Rabies Immunoglobulin (ERIG) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Italy Equine Rabies Immunoglobulin (ERIG) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Russia Equine Rabies Immunoglobulin (ERIG) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Asia Pacific Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Region (2019-2030)
Figure 34. Asia Pacific Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Region (2019-2030)
Figure 35. China Equine Rabies Immunoglobulin (ERIG) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. Japan Equine Rabies Immunoglobulin (ERIG) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. South Korea Equine Rabies Immunoglobulin (ERIG) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. India Equine Rabies Immunoglobulin (ERIG) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Australia Equine Rabies Immunoglobulin (ERIG) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. China Taiwan Equine Rabies Immunoglobulin (ERIG) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Indonesia Equine Rabies Immunoglobulin (ERIG) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Thailand Equine Rabies Immunoglobulin (ERIG) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Malaysia Equine Rabies Immunoglobulin (ERIG) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Latin America Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Country (2019-2030)
Figure 45. Latin America Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Country (2019-2030)
Figure 46. Mexico Equine Rabies Immunoglobulin (ERIG) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Brazil Equine Rabies Immunoglobulin (ERIG) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Argentina Equine Rabies Immunoglobulin (ERIG) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Middle East & Africa Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Country (2019-2030)
Figure 50. Middle East & Africa Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Country (2019-2030)
Figure 51. Turkey Equine Rabies Immunoglobulin (ERIG) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Saudi Arabia Equine Rabies Immunoglobulin (ERIG) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. UAE Equine Rabies Immunoglobulin (ERIG) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Global Sales Market Share of Equine Rabies Immunoglobulin (ERIG) by Type (2019-2030)
Figure 55. Global Revenue Market Share of Equine Rabies Immunoglobulin (ERIG) by Type (2019-2030)
Figure 56. Global Equine Rabies Immunoglobulin (ERIG) Price (US$/Ton) by Type (2019-2030)
Figure 57. Global Sales Market Share of Equine Rabies Immunoglobulin (ERIG) by Application (2019-2030)
Figure 58. Global Revenue Market Share of Equine Rabies Immunoglobulin (ERIG) by Application (2019-2030)
Figure 59. Global Equine Rabies Immunoglobulin (ERIG) Price (US$/Ton) by Application (2019-2030)
Figure 60. Equine Rabies Immunoglobulin (ERIG) Value Chain
Figure 61. Equine Rabies Immunoglobulin (ERIG) Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
